Loading...
FDA Strategies to Prevent and Respond to Drug Shortages: Finding a Better Way to Predict and Prevent Company Closures
To stave off a shortage of doxorubicin in 2011 and 2012, the FDA expedited the approval of a company’s unapproved manufacturing process. Paying companies sufficiently so that they can invest in their facilities when needed is just one of many steps that could be taken to rectify future shortages.
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MediMedia USA, Inc.
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3737981/ https://ncbi.nlm.nih.gov/pubmed/23946619 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|